OTLK
Outlook Therapeutics Inc.
$1.58
-$0.07(-4.24%)
48
Overall
40
Value
83
Tech
21
Quality
Market Cap
$219.87M
Volume
20.62M
52W Range
$0.16 - $3.39
Target Price
$5.50
EPS Estimates Overview
| Current Quarter | $-0.09 | Next Quarter | $-0.08 |
| Current Year | $-0.48 | Next Year | $-0.22 |
| QoQ Growth | +11.1% | YoY Growth | +54.2% |
| 3Y EPS CAGR | +33.9% | Target Price | $5.50 |
| Consensus | Buy | Upside | +248.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OTLK | $1.58 | -4.2% | 20.62M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Outlook Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW